Safety and Efficacy of NABOTA in Treatment of Essential Blepharospasm

Clinical Study to Evaluate the Efficacy and Safety of Neuronox and Botox With Essential Blepharospasm

NCT03216473 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of BOTOX® (Botulinum Toxin Type A) in Korea

NCT02043145 ·Status: COMPLETED

Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study II

NCT02677805 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Abnormal Contraction or Twitch of the Eyelid

NCT01896895 ·Status: COMPLETED ·Phase: PHASE3

A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GSK1358820 (Botulinum Toxin Type A) in Chinese Subjects With Post-stroke Upper Limb Spasticity

NCT01153815 ·Status: COMPLETED ·Phase: PHASE3

Therapeutic Confirmatory Clinical Trial to Evaluate the Safety and Efficacy of "Hugeltox Inj." in Essential Blepharospasm

NCT01791881 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of 10-Week or Shorter vs 12-Week or Longer Injection Intervals of Botulinum Toxin

NCT05103202 ·Status: COMPLETED

Comparison of Different Botulinum Toxin A Injection Patterns in the Treatment of Blepharospasm

NCT02327728 ·Status: UNKNOWN ·Phase: NA

Pretarsal Versus Preseptal Botulinum Toxin for Patients With Eyelid Spasm

NCT03508882 ·Status: COMPLETED ·Phase: PHASE4

Effects of DaxibotulinumtoxinA for Blepharospasm and Hemifacial Spasm

NCT06195241 ·Status: RECRUITING ·Phase: PHASE4

Intradermal (ID) BOTOX in the Treatment of Facial Fine Lines

NCT04631588 ·Status: COMPLETED ·Phase: PHASE1

A Randomized, Double Blind, Multi-center, Active Drug Controlled, Phase III Clinical Trial to Compare the Safety and Efficacy of DWP450 Versus Botox® in Treatment of Post Stroke Upper Limb Spasticity

NCT01945684 ·Status: COMPLETED ·Phase: PHASE3

A Study To Assess the Safety and Effects of OnabotulinumtoxinA (BOTOX) Intramuscular Injection in Adult Participants With Moderate to Severe Platysma Prominence

NCT04949399 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety Study of GSK1358820 in Japanese Patients With Urinary Incontinence Due to Neurogenic Detrusor Overactivity

NCT02849418 ·Status: COMPLETED ·Phase: PHASE3

Botulinum Toxin A in the Treatment of Hemifacial Spasm

NCT03306940 ·Status: UNKNOWN ·Phase: NA

Efficacy and Safety Study of MT10107 in the Treatment of Glabella Line

NCT03908008 ·Status: COMPLETED ·Phase: PHASE3

A Comparative Study of Botulinum Neurotoxin Type A in Treatment of Moderate to Severe Glabellar Frown Lines

NCT04281095 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Botulinum Toxin Type A Injection Into the Gastrocnemius Muscle for Treatment of Nocturnal Calf Cramps in Patients With Lumbar Spinal Stenosis

NCT02444351 ·Status: COMPLETED ·Phase: NA

A Study Of BOTOX For The Treatment Of Glabellar Lines

NCT00408785 ·Status: COMPLETED ·Phase: PHASE3

BOTOX® for the Treatment of Platysma Prominence

NCT03915067 ·Status: COMPLETED ·Phase: PHASE2

Paralysis of the Orbicularis Muscle of the Eye in the Treatment for Dry Eye

NCT02403219 ·Status: COMPLETED ·Phase: PHASE1

Treatment of Temporo-Myofascial Disorder of Muscular Origin Using Botulinum Toxin: A Prospective Study

NCT02810015 ·Status: UNKNOWN ·Phase: PHASE2

Efficacy and Safety of Botulinum Toxin Type A for Injection to Treat Glabellar Lines

NCT02303002 ·Status: COMPLETED ·Phase: PHASE2

Acetyl Hexapeptide-8 for Blepharospasm

NCT01750346 ·Status: TERMINATED ·Phase: PHASE2

Efficacy and Safety Assessment of Botulax® and BOTOX® for Improvement of Glabellar Lines.

NCT05380154 ·Status: COMPLETED ·Phase: PHASE3